Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
351 JPY | -0.28% | +5.72% | +15.84% |
Chart calendar Taiko Pharmaceutical Co.,Ltd.
Upcoming events on Taiko Pharmaceutical Co.,Ltd.
Past events on Taiko Pharmaceutical Co.,Ltd.
2024-02-08 | Q4 2023 Earnings Release |
2023-11-09 | Q3 2023 Earnings Release |
2023-08-09 | Q2 2023 Earnings Release |
2023-05-11 | Q1 2023 Earnings Release |
2023-02-09 | Q4 2022 Earnings Release |
2022-11-10 | Q3 2022 Earnings Release |
2022-08-11 | Interim 2022 Earnings Release |
2022-05-12 | Q1 2022 Earnings Release |
2022-02-17 | FY 2021 Earnings Release |
2021-11-08 | Q3 2021 Earnings Release |
2021-08-05 | Interim 2021 Earnings Release |
2021-06-28 | Ex-dividend day for dividende intermédiaire |
2021-05-06 | FY 2020 Earnings Release |
2021-02-11 | Q3 2020 Earnings Release |
2020-12-28 | Ex-dividend day for extraordinary dividend |
2020-12-28 | Ex-dividend day for final dividend |
2020-11-11 | Interim 2020 Earnings Release |
2020-09-28 | Ex-dividend day for dividende intermédiaire |
2020-08-11 | Q1 2020 Earnings Release |
2020-06-28 | Ex-dividend day for dividende intermédiaire |
Past dividends on Taiko Pharmaceutical Co.,Ltd.
2021-06-28 | Interim Payment 7 JPY |
2020-12-28 | Bonus Payment 8 JPY |
2020-12-28 | Final Payment 10 JPY |
2020-09-28 | Interim Payment 7 JPY |
2020-03-29 | Bonus Payment 20 JPY |
2020-03-29 | Final Payment 20 JPY |
2019-09-26 | Interim Payment 10 JPY |
2019-03-26 | Final Payment 15 JPY |
2019-03-26 | Bonus Payment 10 JPY |
2018-09-25 | Interim Payment 10 JPY |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales Million JPY | Released Forecast Spread | 10 418 9 800 6.31% | 17 582 18 750 -6.23% | 11 299 11 700 -3.43% | 5 040 | 6 120 |
EBITDA Million JPY | Released Forecast Spread | 2 491 2 250 10.7% | 6 124 6 900 -11.25% | -4 006 -1 500 -167.07% | 0,00 | 0,00 |
EBIT Million JPY | Released Forecast Spread | 2 029 1 700 19.35% | 5 650 5 950 -5.04% | -4 947 -2 500 -97.88% | -3 079 | -1 005 |
Earnings before Tax (EBT) Million JPY | Released Forecast Spread | 1 985 1 600 24.06% | 5 454 6 100 -10.59% | -8 887 -4 240 -109.6% | -4 869 | -3 563 |
Net income Million JPY | Released Forecast Spread | 1 415 1 150 23.04% | 3 851 4 150 -7.2% | -9 594 -3 300 -190.73% | -4 895 | -3 611 |
EPS JPY | Released Forecast Spread | 33,0 26,7 23.43% | 89,2 96,2 -7.3% | -221 -75,7 -191.31% | -112 | -76,3 |
Announcement Date | 14/05/19 | 12/02/21 | 18/02/22 | 10/02/23 | 09/02/24 |
Quarterly results
Fiscal Period | December | 2019 S2 | 2021 S1 | 2021 Q4 | 2021 S2 | 2022 Q1 | 2022 Q2 | 2022 S1 | 2022 Q3 | 2023 Q1 | 2023 S1 | 2023 Q3 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million JPY | Released Forecast Spread | 6 593 | 5 106 6 100 -16.3% | 2 944 3 350 -12.12% | 6 193 6 599 -6.15% | 621 1 800 -65.5% | 1 236 1 200 3% | 1 857 3 000 -38.1% | 1 532 | 1 167 | 2 488 | 1 929 |
EBIT Million JPY | Released Forecast Spread | -2 280 -280 -714.29% | -3 369 -916 -267.79% | -2 667 -215 -1140.47% | -1 672 -550 -204% | -745 -1 000 25.5% | -2 417 -1 550 -55.94% | -333 | -155 | -396 | -48,0 | |
Earnings before Tax (EBT) Million JPY | Released Forecast Spread | -2 901 -240 -1108.75% | -1 743 -550 -216.91% | -1 050 -1 000 -5% | -2 793 -1 550 -80.19% | -387 | -242 | -492 | -45,0 | |||
Net income Million JPY | Released Forecast Spread | -2 372 -150 -1481.33% | -7 647 -1 353 -465.19% | -7 222 -928 -678.23% | -1 748 -550 -217.82% | -1 050 -1 000 -5% | -2 798 -1 550 -80.52% | -384 | -243 | -514 | -48,0 | |
EPS JPY | Released Forecast Spread | -54,6 | -40,1 | -64,2 | -8,80 | -5,59 | -11,4 | -0,73 | ||||
Announcement Date | 14/05/19 | 06/08/21 | 18/02/22 | 18/02/22 | 13/05/22 | 12/08/22 | 12/08/22 | 11/11/22 | 12/05/23 | 10/08/23 | 10/11/23 |
Past sector events for Taiko Pharmaceutical Co.,Ltd.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- 4574 Stock
- Calendar Taiko Pharmaceutical Co.,Ltd.